Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.
Metabolic syndrome is associated with a greater risk for excessive scarring, with several specific metabolic components linked to higher risk.
While no association was observed between use of biologics and incident PsA overall, specific biologic classes were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results